Baxter International Inc. (BAX)
31.19
0.37 (1.20%)
At close: Feb 18, 2025, 3:59 PM
31.20
0.03%
After-hours: Feb 18, 2025, 04:11 PM EST
undefined% (undefined)
| Bid | 30.81 |
| Market Cap | 15.93B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 0.25 |
| PE Ratio (ttm) | 124.76 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 31.55 |
| Volume | 3,092,139 |
| Avg. Volume (20D) | 4,571,052 |
| Open | 30.72 |
| Previous Close | 30.82 |
| Day's Range | 30.57 - 31.23 |
| 52-Week Range | 28.34 - 44.01 |
| Beta | undefined |
About BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nu...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Oct 27, 1981
Employees 60,000
Stock Exchange NYSE
Ticker Symbol BAX
Website https://www.baxter.com
Analyst Forecast
According to 9 analyst ratings, the average rating for BAX stock is "Hold." The 12-month stock price forecast is $40, which is an increase of 28.25% from the latest price.
Buy 22.22%
Hold 66.67%
Sell 11.11%
Next Earnings Release
Baxter International Inc. is scheduled to release its earnings on Feb 20, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-3.88%
Baxter International shares are trading lower afte...
Unlock content with
Pro Subscription
6 months ago
-6.55%
Baxter shares are trading lower after the company announced a definitive agreement to divest its Vantive Kidney Care segment to Carlyle for $3.8 billion. The stock initially gained following the announcement but has since reversed.
